Description
Urolithin A is a secondary metabolite of the natural polyphenol compound ellagitannin, which has anti-inflammatory, anti-aging, mitochondrial autophagy-inducing, and antioxidant effects. It can cross the blood-brain barrier and inhibit the PI3K/Akt/mTOR signaling pathway. Urolithin A plays an important role in the treatment of various diseases, such as cancer, Alzheimer's disease, obesity and diabetes.
Features
Purity≥98%
Standardized production, using factory mass production mode
Specifications
|
Cat.No. |
53241ES08/53241ES10/53241ES25 |
|
Size |
5 mg/10 mg/25 mg |
|
Synonym |
Urolithin A |
|
Target |
Human Endogenous Metabolite |
|
CAS No. |
1143-70-0 |
|
Molecular formula |
C13H8O4 |
|
Molecular weight |
228.20 |
|
Appearance |
solid powder |
|
Purity |
≥98% |
|
Solubility |
Soluble in DMSO |
|
Structure |
|
Components
|
Components No. |
Name |
53241ES08 |
53241ES10 |
53241ES25 |
|
53241 |
Urolithin A |
5 mg |
10 mg |
25 mg |
Shipping and Storage
The Urolithin A products should be stored at -15～-25℃ for 3 years. Avoid repeated freeze-thaw cycles.
Documents:
Safety Data Sheet
Manuals
Payment & Security
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.
Inquiry
You may also like
FAQ
The product is for research purposes only and is not intended for therapeutic or diagnostic use in humans or animals. Products and content are protected by patents, trademarks, and copyrights owned by Yeasen Biotechnology. Trademark symbols indicate the country of origin, not necessarily registration in all regions.
Certain applications may require additional third-party intellectual property rights.
Yeasen is dedicated to ethical science, believing our research should address critical questions while ensuring safety and ethical standards.